“Use of a Personalized Clinical Decision Support System for Dosing in Psychopharmacotherapy in Patients with Alcoholic Hallucinosis Based on Pharmacogenomic Markers” has been added to your cart. View cart
Armed with this information, the healthcare professional may be better able to understand and evaluate the clinical evidence for the use of medications for the treatment of bipolar disorder and schizophrenia.
Grants an Individual with Unlimited Access To Over 10,000 Journal Article Pages and Supplements with a Digital Subscription to Psychopharmacology Bulletin